BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

530 related articles for article (PubMed ID: 21883849)

  • 41. Effectiveness of adjuvant chemotherapy in transitional cell carcinoma of the urinary bladder with lymph node involvement and/or lymphovascular invasion treated by radical cystectomy.
    Park J; Park S; Song C; Doo C; Cho YM; Ahn H; Kim CS
    Urology; 2007 Aug; 70(2):257-62. PubMed ID: 17826485
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Clinical analysis of bladder cancer patients undergoing radical cystectomy].
    Kato Y; Hasegawa Y; Wakita T; Hayashi N
    Hinyokika Kiyo; 2005 Nov; 51(11):719-25. PubMed ID: 16363702
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison of american joint committee on cancer pathological stage T2a versus T2b urothelial carcinoma: analysis of patient outcomes in organ confined bladder cancer.
    Boudreaux KJ; Clark PE; Lowrance WT; Rumohr JA; Barocas DA; Cookson MS; Smith JA; Chang SS
    J Urol; 2009 Feb; 181(2):540-5; discussion 546. PubMed ID: 19084855
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prognostic risk stratification of pathological stage T2N0 bladder cancer after radical cystectomy.
    Sonpavde G; Khan MM; Svatek RS; Lee R; Novara G; Tilki D; Lerner SP; Amiel GE; Skinner E; Karakiewicz PI; Bastian PJ; Kassouf W; Fritsche HM; Izawa JI; Ficarra V; Dinney CP; Lotan Y; Fradet Y; Shariat SF
    BJU Int; 2011 Sep; 108(5):687-92. PubMed ID: 21087453
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Contemporary Trends and Efficacy of Pelvic Lymph Node Dissection at Radical Cystectomy for Urothelial and Variant Histology Carcinoma of the Urinary Bladder.
    Kosiba M; Stolzenbach LF; Collà Ruvolo C; Nocera L; Mansour M; Tian Z; Roos FC; Becker A; Kluth LA; Tilki D; Shariat SF; Saad F; Chun FKH; Karakiewicz PI
    Clin Genitourin Cancer; 2022 Apr; 20(2):195.e1-195.e8. PubMed ID: 34906434
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Radical cystectomy in the treatment for bladder carcinoma: results of 125 operated patients].
    Babjuk M; Hanus T; Safarík L; Dvorácek J; Pavlík I; Dusková J
    Cas Lek Cesk; 2007; 146(10):746-50. PubMed ID: 18020005
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Surgical treatment for clinical node-positive bladder cancer patients treated with radical cystectomy without neoadjuvant chemotherapy.
    Moschini M; Mattei A; Cornelius J; Shariat SF; Dell'Oglio P; Zaffuto E; Salonia A; Montorsi F; Briganti A; Colombo R; Gallina A
    World J Urol; 2018 Apr; 36(4):639-644. PubMed ID: 29368231
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Lymphadenectomy for bladder cancer: indications and controversies.
    Burkhard FC; Roth B; Zehnder P; Studer UE
    Urol Clin North Am; 2011 Nov; 38(4):397-405, v. PubMed ID: 22045171
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison of American Joint Committee on Cancer pathologic stage T3a versus T3b urothelial carcinoma: analysis of patient outcomes.
    Boudreaux KJ; Chang SS; Lowrance WT; Rumohr JA; Barocas DA; Cookson MS; Smith JA; Clark PE
    Cancer; 2009 Feb; 115(4):770-5. PubMed ID: 19152431
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Extent of pelvic lymphadenectomy and its impact on outcome in patients diagnosed with bladder cancer: analysis of data from the Surveillance, Epidemiology and End Results Program data base.
    Konety BR; Joslyn SA; O'Donnell MA
    J Urol; 2003 Mar; 169(3):946-50. PubMed ID: 12576819
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Predictors of survival in patients with soft tissue surgical margin involvement at radical cystectomy.
    Xylinas E; Rink M; Novara G; Green DA; Clozel T; Fritsche HM; Guillonneau B; Lotan Y; Kassouf W; Tilki D; Babjuk M; Karakiewicz PI; Montorsi F; Abdennabi J; Trinh QD; Svatek RS; Scherr DS; Zerbib M; Shariat SF
    Ann Surg Oncol; 2013 Mar; 20(3):1027-34. PubMed ID: 23099729
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Extranodal extension is a powerful prognostic factor in bladder cancer patients with lymph node metastasis.
    Fajkovic H; Cha EK; Jeldres C; Robinson BD; Rink M; Xylinas E; Chromecki TF; Breinl E; Svatek RS; Donner G; Tagawa ST; Tilki D; Bastian PJ; Karakiewicz PI; Volkmer BG; Novara G; Joual A; Faison T; Sonpavde G; Daneshmand S; Lotan Y; Scherr DS; Shariat SF
    Eur Urol; 2013 Nov; 64(5):837-45. PubMed ID: 22877503
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Laparoscopic pelvic lymph node dissection system based on preoperative primary tumour stage (T stage) by computed tomography in urothelial bladder cancer: results of a single-institution prospective study.
    Yuan JB; Zu XB; Miao JG; Wang J; Chen MF; Qi L
    BJU Int; 2013 Jul; 112(2):E87-91. PubMed ID: 23323729
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A critical assessment of the value of lymph node dissection at radical prostatectomy: A population-based study.
    Abdollah F; Schmitges J; Sun M; Tian Z; Briganti A; Shariat SF; Perrotte P; Montorsi F; Karakiewicz PI
    Prostate; 2011 Oct; 71(14):1587-94. PubMed ID: 21480307
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Significance of pelvic lymphadenectomy for the prognosis after radical cystectomy].
    Leissner J; Allhoff EP; Hohenfellner R; Wolf HK
    Zentralbl Chir; 2002 Apr; 127(4):315-21. PubMed ID: 12085284
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The presence of lymphovascular invasion in radical cystectomy specimens from patients with urothelial carcinoma portends a poor clinical prognosis.
    Canter D; Guzzo T; Resnick M; Magerfleisch L; Sonnad S; Bergey M; Tomazewski J; Vaughn D; Van Arsdalen K; Malkowicz B
    BJU Int; 2008 Sep; 102(8):952-7. PubMed ID: 18485042
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Lymph node dissection technique is more important than lymph node count in identifying nodal metastases in radical cystectomy patients: a comparative mapping study.
    Dorin RP; Daneshmand S; Eisenberg MS; Chandrasoma S; Cai J; Miranda G; Nichols PW; Skinner DG; Skinner EC
    Eur Urol; 2011 Nov; 60(5):946-52. PubMed ID: 21802833
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Role of pelvic lymph node dissection in lymph node-negative patients with invasive bladder cancer.
    Shirotake S; Kikuchi E; Matsumoto K; Yazawa S; Kosaka T; Miyajima A; Nakagawa K; Oya M
    Jpn J Clin Oncol; 2010 Mar; 40(3):247-51. PubMed ID: 19887521
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Obesity is associated with worse oncological outcomes in patients treated with radical cystectomy.
    Chromecki TF; Cha EK; Fajkovic H; Rink M; Ehdaie B; Svatek RS; Karakiewicz PI; Lotan Y; Tilki D; Bastian PJ; Daneshmand S; Kassouf W; Durand M; Novara G; Fritsche HM; Burger M; Izawa JI; Brisuda A; Babjuk M; Pummer K; Shariat SF
    BJU Int; 2013 Feb; 111(2):249-55. PubMed ID: 22727036
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Positive surgical margins in soft tissue following radical cystectomy for bladder cancer and cancer specific survival.
    Dotan ZA; Kavanagh K; Yossepowitch O; Kaag M; Olgac S; Donat M; Herr HW
    J Urol; 2007 Dec; 178(6):2308-12; discussion 2313. PubMed ID: 17936804
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.